Columnist Ahna Crum spent years trying to go it alone. Now she knows that freedom comes when she's flocking together with ...
The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application for tolebrutinib for the treatment of non-relapsing ...
A decision on tolebrutinib for treating MS is now set for Sept. 28, after the FDA granted priority review to its approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback